BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 32511838)

  • 1. Clinicopathological characteristics of intraductal papillary neoplasm of the bile duct: a Japan-Korea collaborative study.
    Kubota K; Jang JY; Nakanuma Y; Jang KT; Haruyama Y; Fukushima N; Furukawa T; Hong SM; Sakuraoka Y; Kim H; Matsumoto T; Lee KB; Zen Y; Kim J; Miyazaki M; Choi DW; Heo JS; Endo I; Hwang S; Nakamura M; Han HS; Uemoto S; Park SJ; Hong EK; Nanashima A; Kim DS; Kim JY; Ohta T; Kang KJ; Fukumoto T; Nah YW; Seo HI; Inui K; Yoon DS; Unno M
    J Hepatobiliary Pancreat Sci; 2020 Sep; 27(9):581-597. PubMed ID: 32511838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A statement by the Japan-Korea expert pathologists for future clinicopathological and molecular analyses toward consensus building of intraductal papillary neoplasm of the bile duct through several opinions at the present stage.
    Nakanuma Y; Jang KT; Fukushima N; Furukawa T; Hong SM; Kim H; Lee KB; Zen Y; Jang JY; Kubota K
    J Hepatobiliary Pancreat Sci; 2018 Mar; 25(3):181-187. PubMed ID: 29272078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Tumor Location on Postoperative Outcome of Intraductal Papillary Neoplasm of the Bile Duct.
    Matsumoto T; Kubota K; Hachiya H; Sakuraoka Y; Shiraki T; Shimizu T; Mori S; Iso Y; Kato M; Yamagishi H; Imai Y; Aoki T
    World J Surg; 2019 May; 43(5):1313-1322. PubMed ID: 30659344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological characterization of so-called "cholangiocarcinoma with intraductal papillary growth" with respect to "intraductal papillary neoplasm of bile duct (IPNB)".
    Nakanuma Y; Sato Y; Ojima H; Kanai Y; Aishima S; Yamamoto M; Ariizumi S; Furukawa T; Hayashi H; Unno M; Ohta T;
    Int J Clin Exp Pathol; 2014; 7(6):3112-22. PubMed ID: 25031730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraductal Papillary Neoplasm of Bile Duct: Updated Clinicopathological Characteristics and Molecular and Genetic Alterations.
    Nakanuma Y; Uesaka K; Kakuda Y; Sugino T; Kubota K; Furukawa T; Fukumura Y; Isayama H; Terada T
    J Clin Med; 2020 Dec; 9(12):. PubMed ID: 33317146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraductal papillary neoplasm of the bile duct: review of updated clinicopathological and imaging characteristics.
    Kim JR; Jang KT; Jang JY
    Br J Surg; 2023 Aug; 110(9):1229-1240. PubMed ID: 37463281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative clinicopathological study of biliary intraductal papillary neoplasms and papillary cholangiocarcinomas.
    Fujikura K; Fukumoto T; Ajiki T; Otani K; Kanzawa M; Akita M; Kido M; Ku Y; Itoh T; Zen Y
    Histopathology; 2016 Dec; 69(6):950-961. PubMed ID: 27410028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of intraductal papillary neoplasm of the bile duct in patients with occupational cholangiocarcinoma.
    Kubo S; Tanaka S; Kinoshita M; Shinkawa H; Ishizawa T; Sato Y
    Virchows Arch; 2023 Apr; 482(4):745-753. PubMed ID: 36715769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraductal papillary neoplasms of the bile duct consist of two distinct types specifically associated with clinicopathological features and molecular phenotypes.
    Aoki Y; Mizuma M; Hata T; Aoki T; Omori Y; Ono Y; Mizukami Y; Unno M; Furukawa T
    J Pathol; 2020 May; 251(1):38-48. PubMed ID: 32100878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current status of diagnosis and therapy for intraductal papillary neoplasm of the bile duct.
    Sakai Y; Ohtsuka M; Sugiyama H; Mikata R; Yasui S; Ohno I; Iino Y; Kato J; Tsuyuguchi T; Kato N
    World J Gastroenterol; 2021 Apr; 27(15):1569-1577. PubMed ID: 33958844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraductal papillary neoplasm of the bile duct: Assessment of invasive carcinoma and long-term outcomes using MRI.
    Lee S; Kim MJ; Kim S; Choi D; Jang KT; Park YN
    J Hepatol; 2019 Apr; 70(4):692-699. PubMed ID: 30553839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of Intraductal Papillary Neoplasm of the Bile Duct with Respect to the Histopathologic Similarities to Pancreatic Intraductal Papillary Mucinous Neoplasm.
    Nakanuma Y; Kakuda Y; Uesaka K
    Gut Liver; 2019 Nov; 13(6):617-627. PubMed ID: 30982236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological features and prognosis of mucin-producing bile duct tumor and mucinous cystic tumor of the liver: a multi-institutional study by the Japan Biliary Association.
    Kubota K; Nakanuma Y; Kondo F; Hachiya H; Miyazaki M; Nagino M; Yamamoto M; Isayama H; Tabata M; Kinoshita H; Kamisawa T; Inui K
    J Hepatobiliary Pancreat Sci; 2014 Mar; 21(3):176-85. PubMed ID: 23908126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Premalignant lesions of cholangiocarcinoma: characteristics on ultrasonography and MRI.
    Siripongsakun S; Sapthanakorn W; Mekraksakit P; Vichitpunt S; Chonyuen S; Seetasarn J; Bhumiwat S; Sricharunrat T; Srittanapong S
    Abdom Radiol (NY); 2019 Jun; 44(6):2133-2146. PubMed ID: 30820627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological Aspects and Diagnostic Problems in Patients with Intraductal Papillary Neoplasm of the Bile Duct.
    Nanashima A; Imamura N; Sumida Y; Hiyoshi M; Hamada T; Nagayasu T
    Anticancer Res; 2018 Apr; 38(4):2343-2352. PubMed ID: 29599359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological Study of Resections of Intraductal Papillary Neoplasm of the Bile Duct.
    Sato T; Hisaka T; Sakai H; Ishikawa H; Kawahara R; Goto Y; Nomura Y; Yasunaga M; Fujita F; Tanigawa M; Naito Y; Akiba J; Yano H; Tanaka H; Akagi Y; Okuda K
    Anticancer Res; 2019 Aug; 39(8):4569-4573. PubMed ID: 31366561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted next-generation sequencing identifies distinct clinicopathologic and molecular entities of intraductal papillary neoplasms of the bile duct.
    Yang CY; Huang WJ; Tsai JH; Cheng A; Chen CC; Hsu HP; Jeng YM
    Mod Pathol; 2019 Nov; 32(11):1637-1645. PubMed ID: 31231124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A clinicopathological reappraisal of intraductal papillary neoplasm of the bile duct (IPNB): a continuous spectrum with papillary cholangiocarcinoma in 181 curatively resected cases.
    Onoe S; Ebata T; Yokoyama Y; Igami T; Mizuno T; Yamaguchi J; Watanabe N; Otsuka S; Nakamura S; Shimoyama Y; Nagino M
    HPB (Oxford); 2021 Oct; 23(10):1525-1532. PubMed ID: 33832834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological features of intraductal papillary neoplasms of the bile duct: a comparison with intraductal papillary mucinous neoplasm of the pancreas with reference to subtypes.
    Fukumura Y; Nakanuma Y; Kakuda Y; Takase M; Yao T
    Virchows Arch; 2017 Jul; 471(1):65-76. PubMed ID: 28550497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathologic characteristics and long-term prognosis of intraductal papillary neoplasm of the bile duct: a retrospective study.
    Wu X; Li B; Zheng C
    Eur J Med Res; 2023 Mar; 28(1):132. PubMed ID: 36945047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.